Clonazepam in the treatment of psychiatric disorders: an update

International Clinical Psychopharmacology
Antonio E Nardi, Giampaolo Perna

Abstract

An updated overview over the past decade is provided with respect to the use of clonazepam in a variety of psychiatric disorders. The efficacy of clonazepam monotherapy for the short-term treatment of panic disorder (PD) was fully established in two large pivotal multicentre studies in the late 1990s in a total of >800 patients. Other studies support a role for clonazepam, in association with selective serotonin reuptake inhibitors (SSRIs), to accelerate treatment response in PD. Although some longitudinal data suggest an ability to maintain improvement without tolerance for up to 3 years, long-term controlled studies of clonazepam in PD are lacking. Studies have shown that clonazepam can also block CO2-induced panic and improve certain aspects of quality of life in PD. Clonazepam has shown some efficacy in social phobia; however, because this evidence is based on few studies, further studies are warranted before definitive conclusions can be drawn. Finally, evidence for the use of clonazepam in acute mania and as augmentation therapy with SSRIs to accelerate response in depression is examined. The long half-life and higher potency of clonazepam may allow easier discontinuation with fewer withdrawal symptoms compared to other b...Continue Reading

References

Nov 1, 1992·Clinical Pharmacology and Therapeutics·D J GreenblattJ S Harmatz
Dec 1, 1992·Journal of Clinical Psychopharmacology·W A HewlettW S Agras
Oct 1, 1991·Archives of General Psychiatry·C S GelernterJ J Bartko
Aug 1, 1994·Journal of Clinical Psychopharmacology·L A LabbateJ F Rosenbaum
Aug 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·A C BriggsS Brandon
Dec 1, 1993·Journal of Clinical Psychopharmacology·J R DavidsonW H Wilson
Mar 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·F GraaeR G Klein
Jan 1, 1993·Archives of General Psychiatry·K RickelsS Zavodnick
Feb 1, 1996·Acta Psychiatrica Scandinavica·G GouliaevL Bjerre
Dec 1, 1996·The Journal of Nervous and Mental Disease·S M SutherlandJ R Davidson
Jul 1, 1997·International Journal of Geriatric Psychiatry·P A CalkinR Workman
Jun 25, 1998·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J A BennettP E Keck
Oct 28, 1998·Journal of Clinical Psychopharmacology·K M ConnorF Ferrell
Jun 22, 1999·International Journal of Psychiatry in Medicine·L R WulsinV E Wells
Jul 15, 1999·Journal of Affective Disorders·S Morishita, S Aoki
Aug 18, 1999·Arquivos de neuro-psiquiatria·A E NardiI Nascimento
Feb 1, 2000·Journal of Clinical Psychopharmacology·P L BonateC Oo
Mar 30, 2000·The American Journal of Psychiatry·J M GormanJ D Coplan
Dec 6, 2000·Arquivos de neuro-psiquiatria·A M ValençaW Zin
Jul 31, 2001·Archives of General Psychiatry·A W GoddardD Charney
May 15, 2002·Journal of Clinical Psychopharmacology·Matig R Mavissakalian, James M Perel
Jul 20, 2002·Journal of Affective Disorders·Ward T SmithUNKNOWN Summit Research Network
Jul 20, 2002·Arquivos de neuro-psiquiatria·Alexandre M ValençaMárcio Versiani
Aug 9, 2002·Journal of Affective Disorders·Shigeru Morishita, Shozo Aoki
Nov 27, 2002·Psychiatry Research·Alexandre M ValençaMarcio Versiani
Feb 13, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Eric HollanderStephen M Stahl
Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·M Versiani
Mar 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Dietmar WinklerSiegfried Kasper
Jul 19, 2003·São Paulo Medical Journal = Revista Paulista De Medicina·Alexandre Martins ValençaMarcio Versiani
Aug 6, 2003·The American Journal of Psychiatry·Steven E BruceMartin B Keller
Aug 6, 2003·Depression and Anxiety·Carlos BlancoMichael R Liebowitz
Sep 30, 2003·Journal of Psychopharmacology·Mark H PollackMichael W Otto
Nov 5, 2003·São Paulo Medical Journal = Revista Paulista De Medicina·Heloisa Bettiol
Feb 10, 2004·CNS Spectrums·Michael Van AmeringenUNKNOWN World Council of Anxiety
Mar 12, 2004·Journal of Affective Disorders·François Curtin, Pierre Schulz
Nov 3, 2004·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Barbara A CrockettJonathan R T Davidson

❮ Previous
Next ❯

Citations

Nov 5, 2010·Biological & Pharmaceutical Bulletin·Masahiko HayashiTeruo Tsuchiya
Oct 18, 2011·Expert Opinion on Emerging Drugs·Giampaolo PernaDaniela Caldirola
Jul 3, 2007·Journal of Affective Disorders·Antonio Egidio NardiMarcio Versiani
Apr 16, 2014·Frontiers in Behavioral Neuroscience·Anna MikuleckáHana Kubová
Apr 29, 2016·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Sheng-Min WangKyoung-Uk Lee
Jul 6, 2016·The Indian Journal of Medical Research·Adarsh TripathiNaotaka Shinfuku
Sep 18, 2016·The International Journal of Neuropsychopharmacology·Katalin TóthKatalin Monostory
Aug 2, 2007·The Annals of Pharmacotherapy·Murat ColakoğluTekin Akpolat
Dec 28, 2006·Human Psychopharmacology·Shigeru Morishita, Seizaburo Arita
Jan 24, 2018·Expert Opinion on Drug Safety·Laiana A QuagliatoAntonio E Nardi
Aug 1, 2020·Frontiers in Neurology·Amber RoguskiMichal Rolinski
May 16, 2017·Depression and Anxiety·Heide KuangMichael H Bloch
Aug 4, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrew D Krystal
Mar 30, 2021·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Carla Patrícia de Morais CouraCélia Martins Cortez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.